At meeting held on 24 November 2021
The Board of Ipca Laboratories at its meeting held on 24 November 2021 has approved the acquisition of 26.574% of the paid-up share capital of Lyka Labs and entering into a Joint Management Control Agreement with the Promoters of the said company.Lyka Labs is a company incorporated in the year 1976 under Companies Act, 1956 and is engaged in the business of manufacturing and marketing of injectables, lyophilized injectables and topical formulations.
Consequent to this acquisition of shares, the Company has also, made a public announcement to acquire 26% additional equity shares of the said company from its public shareholders under the SEBI (SAST) Regulations, 2011.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
